Seth Flaum Joined McDermott Will & Emery

The health and life sciences veteran moves to the firm's New York practice.

Updated on Oct. 6, 2026 in Biotech

Isometric editorial illustration of a clean, geometric architectural corridor in a modern skyscraper, representing professional institutional structure.
Seth Flaum has joined McDermott Will & Emery as a partner, focusing on the firm's health and life sciences practice in New York. AI Illustration. Upload story photo >

Seth Flaum has joined McDermott Will & Emery as a partner. He will focus on work within the firm's health and life sciences practice group based in New York.

Why it matters

The firm is strengthening its legal expertise within the life sciences sector. This addition marks a strategic shift in personnel between prominent legal entities operating in the health space.

The hiring of a single partner constitutes the entirety of the announced staffing change. This headcount adjustment reflects the current growth strategy of the firm's New York health and life sciences practice.

The players

Seth Flaum

A legal partner specializing in health and life sciences who previously practiced at Wilson Sonsini.

McDermott Will & Emery

An international law firm with an extensive health and life sciences practice group.

Wilson Sonsini

A law firm known for representing technology and life sciences companies in corporate and regulatory matters.

The details

Seth Flaum joins McDermott Will & Emery after a tenure at Wilson Sonsini, a law firm recognized for its work with technology and life sciences companies. He operates as a partner specifically within the health and life sciences group. This integration of legal talent aims to support complex regulatory and commercial needs for clients in the biotech and healthcare fields.

Timeline

  1. October 6, 2026: The firm announced the hiring of Seth Flaum.

The Tech Race

This hiring follows the 2026 legal market talent migration trends for high-stakes health litigation. It underscores the ongoing competition among top-tier firms to secure specialized legal counsel capable of navigating the complex regulatory landscapes of modern biotech.

New York City-based life sciences firms may see changes in their legal service providers as talent moves between major practices. Clients should monitor future filings to determine if this partner transition impacts their current representation.

The takeaway

The movement of seasoned partners between established law firms is a key indicator of where the industry is prioritizing its legal resources. Watch for how this hiring influences the firm's caseload in the health and life sciences sector over the coming fiscal year.

Further reading

For more on how legal shifts influence the industry, see our Biotech section.

Source note: This article includes information reported by Bloomberglaw.